biotin has been researched along with Deep Vein Thrombosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandao, GM; Junqueira, DR; Rollo, HA; Sobreira, ML | 1 |
| Nieto Rodríguez, JA | 1 |
| Boëlle, E; Cortez, P; Destors, JM; Paty, I; Sanderink, G; Trellu, M | 1 |
| Boëlle, E; Cheng, S; Cortez, P; Donat, F; Fau, JB; Paty, I; Sanderink, GJ; Trellu, M | 1 |
2 review(s) available for biotin and Deep Vein Thrombosis
| Article | Year |
|---|---|
Pentasaccharides for the treatment of deep vein thrombosis.
Topics: Anticoagulants; Biotin; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Oligosaccharides; Polysaccharides; Randomized Controlled Trials as Topic; Recurrence; Time Factors; Venous Thrombosis | 2017 |
[New approaches in the treatment of deep vein thrombosis].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Biotin; Clinical Trials, Phase III as Topic; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thrombosis | 2012 |
3 trial(s) available for biotin and Deep Vein Thrombosis
| Article | Year |
|---|---|
Reversibility of the anti-FXa activity of idrabiotaparinux (biotinylated idraparinux) by intravenous avidin infusion.
Topics: Adolescent; Adult; Anticoagulants; Avidin; Biotin; Coagulants; Dose-Response Relationship, Drug; Double-Blind Method; Factor Xa Inhibitors; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lower Extremity; Male; Oligosaccharides; Prospective Studies; Secondary Prevention; Time Factors; Treatment Outcome; Venous Thrombosis; Young Adult | 2010 |
Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis.
Topics: Adult; Aged; Anticoagulants; Biotin; Blood Coagulation; Double-Blind Method; Drug Administration Schedule; Europe; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Injections, Subcutaneous; Male; Middle Aged; Oligosaccharides; Recurrence; Risk Assessment; Time Factors; Treatment Outcome; United States; Venous Thrombosis | 2011 |
Bioequipotency of idraparinux and idrabiotaparinux after once weekly dosing in healthy volunteers and patients treated for acute deep vein thrombosis.
Topics: Adolescent; Adult; Anticoagulants; Area Under Curve; Biotin; Factor Xa; Factor Xa Inhibitors; Humans; Male; Middle Aged; Oligosaccharides; Therapeutic Equivalency; Venous Thrombosis; Young Adult | 2013 |